Compelo Medical Devices is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More
Close
Dismiss

Work starts at Proton Partners’ first cancer center in Wales, UK

Proton Partners International has started work at its first cancer center in Newport, Wales, UK.

The centre will be located at the Earth Balance wellness site in Bomarsund, Northumberland and it is expected to be completed in early 2018.

The cancer centre will be able to treat up to 500 patients every year and the treatment will include not only proton beam therapy but also imaging, chemotherapy, traditional radiotherapy and well-being.

Proton Partners International CEO Mike Moran said: “Today marks an important step in our plans to revolutionise cancer treatment across the UK. 

“Northumberland is the perfect location for our second centre– it is close to well-connected transport links and opens the door to proton beam therapy to prospective patients from the North of England and Scotland.

“We have acquired the best technology available and our aim is that this area will evolve into a state of the art cancer treatment facility. The investment will also bring jobs, medical and administrative, to the area and will attract skilled individuals to the North East.”

According to Proton Partners, there are no proton therapy centres operating in the UK and the demand for specialised cancer care is increasing.

The company claims that it is at the helm of providing proton beam therapy in the UK and says that it has partnered with world-class providers that can outfit its facilities with high quality equipment.

Proton Partners International chief medical officer Karol Sikora said: “There is a pressing need to bring this type of treatment to the UK as studies have shown that at least 10% of patients who receive traditional radiotherapy would be treated more effectively with protons.

“By offering a variety of cancer therapies, our centres will deliver a fully comprehensive level of cancer care, tailored to fit the different needs of each patient – something which is not available in the UK at the moment.”